What sector does Sabra Health Care REIT belong to?

Sabra Health Care REIT operates in the Real Estate sector, specifically the Health Care REITs industry, and is listed on the US markets.

What is the current share price of SBRA?

As of the latest available quote, SBRA traded at $20.52. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of SBRA?

Sabra Health Care REIT has a price-to-earnings (P/E) ratio of about 78.92. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of SBRA?

The market capitalisation of Sabra Health Care REIT is approximately $4.99B.

Is Sabra Health Care REIT profitable?

For its latest reported financial year, Sabra Health Care REIT recorded a net profit margin of about 43.60%.

Does SBRA pay a dividend?

Sabra Health Care REIT currently has a dividend yield of about 5.76%.

What is the return on equity (ROE) of SBRA?

Sabra Health Care REIT has a return on equity (ROE) of about 5.66%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of SBRA?

Over the past 52 weeks, SBRA has traded between a low of $17.17 and a high of $22.77.

Sabra Health Care REIT

SBRA US Real Estate Health Care REITs

S&P 400

$20.52

-1.49%

Delayed · cached 15 min

Fair value analysis

SBRA

Sabra Health Care REIT

$20.52

Close used for this calculation

$11.66Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

41/100

Profitability14/25

Returns3/25

Balance Sheet11/25

Efficiency13/25

Growth6/25

Average

Quality radar

Consensus fair value

$11.66

Above FV

▼ -43.2% against the close used

Model range $1.39 – $15.31

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear$1.39Fair value$11.66Bull$15.31

FairClose

52-week traded range

52W low $17.2352W high $22.39

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Sabra Health Care REIT closed at $20.52, 76.0% above the consensus fair value of $11.66 drawn from 8 valuation models.

Financial DNA score 41/100 — Average. P/E of 32.1x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

$12.00

-41.5%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=8%, r=10%, tg=3%, n=10yr

Graham Number

$12.54

-38.9%

√(22.5 × EPS × BVPS)

EPS=0.64, BVPS=10.91 · outside Graham range (P/E 32.1, P/B 1.9) — asset-light, treat as a rough floor

P/E Fair Value

$12.80

-37.6%

EPS × 20x (sector P/E)

EPS=0.64, Sector P/E=20x

Peter Lynch (PEG)

$1.39

-93.2%

EPS × Growth% (PEG = 1 is fair)

EPS=0.64, g=2.2%

Dividend Discount (DDM)

$15.31

-25.4%

D1 ÷ (r − g) where D1 = D0×(1+g)

D0=1.2, r=10%, g=2%

Book Value (P/B)

$4.15

-79.8%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=10.91, ROE=5.7%, g=3%, r=10%

Reverse DCF

$20.52

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 13.5% | Historical: -2.2%

Margin of Safety

$9.34

-54.5%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=12.45, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer